Bumetanide Drug Study WWW RNpedia Com
Bumetanide Drug Study WWW RNpedia Com
com
“Nursing Notes and Community”
Drug Name Dosages Therapeutic Indications Adverse effects Contraindicati Nursing considerations
Actions ons
bumetanide Oral • Bumetanide • Edema • Muscle cramps, Hypersensitivi Assessment
(byoo met' a induces diuresis associated with dizziness, ty,
nide) • edema by inhibiting CHF, cirrhosis, hypotension, progressive • History: Allergy to bumetanide,
Bumex, o Adult: 1 mg reabsorption of renal disease headache, renal failure electrolyte depletion, anuria,
Burinex (CAN) once daily. water and • IV: Acute nausea, and anuria, severe renal failure, hepatic
Give 2nd dose electrolytes pulmonary impaired hepatic coma, coma, SLE, gout, diabetes
Pregnancy 6-8 hr later if (sodium and edema hearing, severe mellitus, lactation
Category C necessary. chloride) in the • Unlabeled use: pruritus, ECG electrolyte • Physical: Skin color, lesions;
o Elderly: 0.5 mg ascending loop Treatment of changes, depletion. edema; orientation, reflexes,
Drug class of Henle and adult nocturia musculoskeletal hearing; pulses, baseline ECG,
daily.
proximal renal (not effective in pain, rash, BP, orthostatic BP, perfusion;
• Refractory
• Loop (high- tubule. men with BPH) chest R, pattern, adventitious
edema
ceiling) discomfort, sounds; liver evaluation, bowel
o Adult: Initially,
diuretic Absorption: renal failure, sounds; urinary output
5 mg daily
Almost completely premature patterns; CBC, serum
increased by 5
and rapidly ejaculation, electrolytes (including calcium),
mg every 12-24
absorbed from the thrombocytope blood glucose, LFTs, renal
hr as required.
GIT. nia, function tests, uric acid,
High doses
Distribution: 95% hypokalaemia, urinalysis
may be divided
bound to plasma hypomagnesae
in 2-3 doses.
proteins. mia,
Max: 10 Interventions
Excretion: hyponatraemia,
mg/day.
Elimination half-life: hyperuricaemia,
• hypertensio hyperglycaemia • Give with food or milk to
n about 1-2 hr. About
80% excreted in , prevent GI upset.
o Adult: 0.5-1 hypocalcaemia. • Mark calendars or use
the urine; 50% as
mg daily. Max: reminders if intermittent
unchanged drug. • Potentially
5 mg/day. therapy is best for treating
Fatal:
Encephalopath edema.
Intravenous y (in patients • Give single dose early in day
with preexisting so increased urination will not
• pulmonary liver disease). disturb sleep.
edema • Avoid IV use if oral use is
• Adult: 1-2 mg IV possible.
repeated 20 min • BLACK BOX WARNING:
later if necessary, Arrange to monitor serum
or 2-5 mg in 500 electrolytes, hydration, liver
ml of a suitable function during long-term
infusion fluid therapy, water and electrolyte
given over 30-60 depletion can occur.
RNpedia.com
“Nursing Notes and Community”
min. • Provide diet rich in potassium
or supplemental potassium.
Parenteral
Teaching points
• Emergency cases
of edema • Record alternate day or
• Adult: 0.5-1 mg intermittent therapy on a
via slow IV/IM inj, calendar or dated envelopes.
subsequently • Take the drug early in day so
adjust dose increased urination will not
according to disturb sleep; take with food or
response. meals to prevent GI upset.
• Weigh yourself on a regular
basis, at the same time and in
the same clothing; record the
weight on your calendar.
• You may experience these side
effects: Increased volume and
frequency of urination;
dizziness, feeling faint on
arising, drowsiness (avoid rapid
position changes; hazardous
activities, such as driving; and
alcohol consumption);
sensitivity to sunlight (use
sunglasses, sunscreen, wear
protective clothing); increased
thirst (suck sugarless lozenges;
use frequent mouth care); loss
of body potassium (a
potassium-rich diet, or
supplement will be needed).
• Report weight change of more
than 3 pounds in 1 day;
swelling in ankles or fingers;
unusual bleeding or bruising;
nausea, dizziness, trembling,
numbness, fatigue; muscle
weakness or cramps.